首页> 美国卫生研究院文献>The Journal of Reproduction and Development >Developmental competence of interspecies cloned embryos produced using cells from large Japanese field mice (Apodemus speciosus) and oocytes fromlaboratory mice (Mus musculus domesticus)
【2h】

Developmental competence of interspecies cloned embryos produced using cells from large Japanese field mice (Apodemus speciosus) and oocytes fromlaboratory mice (Mus musculus domesticus)

机译:利用大型日本田鼠(Apodemus speciosus)的细胞和来自日本的田鼠卵母细胞产生的种间克隆胚胎的发育能力实验小鼠(家蝇)

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The large Japanese field mouse ( ) is endemic to Japan and may be used as an animal model for studies related to environmental pollution, medicalscience, and basic biology. However, the large Japanese field mouse has low reproductive ability due to the small number of oocytes ovulated per female. To produce experimentalmodels, we investigated the developmental potential of interspecies somatic cell nuclear transfer (iSCNT) embryos produced by fusing tail tip cells fromthe large Japanese field mouse with enucleated oocytes from laboratory mice ( ). Only a small number of iSCNT embryos developed to the 4-cell(0–4%) and blastocysts (0–1%) stages under sequential treatment using trichostatin A (TSA) and vitamin C (VC) supplemented with deionized bovine serum albumin (d-BSA). Thissequential treatment led to the reduction in H3K9 trimethylation and did not affect H3K4 trimethylation in at least the 2-cell stage of the iSCNT embryos. Moreover, iSCNT embryosthat received tail tip cells with exposure treatment to ooplasm from cell fusion to oocyte activation or VC treatment prior to cell fusion did not exhibit significant development improvement compared to that of each control group. This suggests that large Japanese field mice/laboratory mice iSCNT embryos that received sequentialtreatment using TSA and VC with d-BSA may have slightly better developmental potential beyond the 4-cell stage. Our results provide insights into the reprogramming barriersimpeding the wider implementation of iSCNT technology.
机译:日本大型田鼠()是日本特有的,可以用作与环境污染,医学相关的研究的动物模型科学和基础生物学。但是,由于每只雌性排卵的卵母细胞数量少,日本大型田鼠的繁殖能力低。进行实验模型中,我们研究了通过融合尾尖细胞产生的种间体细胞核移植(iSCNT)胚胎的发展潜力日本的大型田鼠,带有实验室小鼠去核卵母细胞()。仅少数iSCNT胚胎发育为4细胞(3–4%)和囊胚(0–1%)在使用曲古抑菌素A(TSA)和维生素C(VC)补充去离子牛血清白蛋白(d-BSA)的顺序治疗下进行。这个顺序处理导致iSCNT胚胎至少2细胞阶段的H3K9三甲基化减少,并且不影响H3K4三甲基化。而且,iSCNT胚胎与每个对照组相比,接受了从细胞融合到卵母细胞活化或在细胞融合前进行VC处理的暴露于卵质的尾尖细胞的细胞,未显示出显着的发育改善。这表明接受序贯性的大型日本田鼠/实验室小鼠iSCNT胚胎使用TSA和VC与d-BSA联合治疗可能在4细胞阶段后具有更好的发展潜力。我们的结果提供了对重新编程障碍的见解阻碍了iSCNT技术的广泛实施。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号